A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Poland- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Ul. Polnocna 24/U1, 20-064 Lublin, Poland
Clinirem Sp. z o.o. in Lublin, Poland specialises in clinical trials of conditions such as Chronic inflammatory demyelinating polyradiculoneuropathy, Myasthenia gravis, Dementia Alzheimer's type, Migraine, and other specialisations. This site conducts important research.
At Clinirem Sp. z o.o. in Lublin, clinical research in nervous system diseases focuses on episodic migraine. The studies are designed to evaluate whether a new treatment can help reduce migraine burden and improve symptom control for people living with frequent attacks.
This research supports better options for preventing migraines and improving everyday functioning for patients affected by recurrent headache disorders.
The site is also conducting work in immune system diseases, with a strong emphasis on generalized myasthenia gravis. These trials aim to understand whether a new therapy can be safe and effective for people with this chronic autoimmune condition that affects muscle strength.
Through this work, Clinirem Sp. z o.o. contributes to advancing treatment choices for patients living with complex immune-related disorders.
Clinical trials currently enrolling participants at this site.
PolandOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
PolandPharmacokinetics and safety of subcutaneous vs intravenous human normal immunoglobulin in adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
PolandAUR200 for Patients with Generalized Myasthenia Gravis
PolandA Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse
PolandStudy of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo
PolandComparison of TAK-881 and HyQvia for adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
PolandStudy on the Safety and Effectiveness of NMD670 for Adults with Myasthenia Gravis
PolandStudy on Nipocalimab for Adults with Generalized Myasthenia Gravis
PolandStudy on Long-term Safety and Efficacy of Efgartigimod PH20 SC in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
PolandStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
PolandStudy on Long-Term Safety and Effectiveness of Zilucoplan in Adults with Generalized Myasthenia Gravis
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.